SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) today announced that Kim Blickenstaff, Biosite's chairman and
chief executive officer, and Ken Buechler, Ph.D., president and chief
scientific officer, will discuss the Company's operating environment, new and
potential products and the company's research and development activities at
the William Blair 25th Annual Growth Stock Conference. Biosite's presentation
will take place Wednesday, June 22, 2005, at 3:20 p.m. Eastern. The
conference is to be held at the Four Seasons Hotel in Chicago.
A link to the live audio webcast and presentation can be accessed through
the Biosite website, http://www.biosite.com. The Biosite presentation will be
archived on the website for 21 days in the Investor and Media section under
Events Calendar.
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.
Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of
U.S. hospitals and in over 50 international markets. Information on Biosite
can be found at http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
Company News On-Call:
http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, Vice President, Corporate and
Investor Relations of Biosite Incorporated, +1-858-455-4808, ext.
3187, npadilla@biosite.com
|
